Top compounds associated with response to IPO4

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	navitoclax:birinapant (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.12	0.001
mRNA	gossypol	CTRPv2	pan-cancer	AAC	0.12	0.001
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.11	0.002
mRNA	navitoclax:MST-312 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.12	0.002
mRNA	Mdivi-1	CTRPv2	pan-cancer	AAC	0.11	0.003
mRNA	ABT-737	CTRPv2	pan-cancer	AAC	-0.11	0.003
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.094	0.003
mRNA	nelarabine	CTRPv2	pan-cancer	AAC	-0.12	0.003
mRNA	JQ-1:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.1	0.003
mRNA	rigosertib	CTRPv2	pan-cancer	AAC	0.096	0.005

Download CSV